IBI: AV628; Miljana Tanić***, naučni savetnik, Institut za onkologiju i radiologiju Srbije u Beogradu; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;
eNauka profil: rp10932; ORCID: 0000-0003-3102-776X;
WOS indikatori: NR = 37; TC = 2754; HIndex = 19;
eNauka WOS indikatori: NR = 60; TC = 2767; HIndex = 20 ;
Lista A broj bodova: 88.46320 (552) 58.0%; Lista B broj bodova: 325.27431 (552) 78.1%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 21.395 (373) 1.3%; Lista B broj bodova kolaboracije: 68.2525 (373) 6.7%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 37 | 34 | 32 | 24 | 22 |
| Broj citata | 2754 | 1717 | |||
| Broj M bodova | 335.00 | 335 | 335.00 | 335 | |
| Normirani broj citata | 449.50 | 325.27 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 88.46 | 88.46 | 88.46 | 88.46 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 15 | 14 | 14 | 14 | 13 |
| Broj citata rezultata sa 20 i više autora | 2360 | 1394 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 240.00 | 240 | 240.00 | 240 | |
| Normirani broj citata rezultata sa 20 i više autora | 136.34 | 68.25 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 21.39 | 21.39 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AV628 | 2012 | E | BREAST CANCER RESEARCH AND TREATMENT Vol. 134 (1): # 41 - 51 (11), (DOI: 10.1007/s10549-011-1905-4) JUL 2012WOS | 33 | 25 | 5 | 0 | 25.0000 | Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway | Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B | 2. | AV628 | 2012 | E | PLOS ONE Vol. 7 (6): #e38847 - (9), (DOI: 10.1371/journal.pone.0038847) JUN 11 2012WOS | 74 | 51 | 8 | 0 | 42.5000 | Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene | Tanic M, Yanowsky K, Rodriguez-Antona C, Andrés R, Márquez-Rodas I, Osorio A, Benitez J, Martinez-Delgado B | 3. | AV628 | 2013 | E | BREAST CANCER RESEARCH AND TREATMENT Vol. 141 (2): # 231 - 242 (12), (DOI: 10.1007/s10549-013-2696-6) SEP 2013WOS | 26 | 23 | 10 | 0 | 14.3750 | Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade | Martinez-Delgado B, Gallardo M, Tanic M, Yanowsky K, Inglada-Perez L, Barroso A, Rodriguez-Pinilla M, Cañamero M, Blasco M, Benitez J | 4. | AV628 | 2013 | E | BRITISH JOURNAL OF CANCER Vol. 109 (10): # 2724 - 2734 (11), (DOI: 10.1038/bjc.2013.612) NOV 12 2013WOS | 18 | 14 | 9 | 0 | 10.0000 | MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours | Tanic M, Andrés E, Rodriguez-Pinilla S, Marquez-Rodas I, Cebollero-Presmanes M, Fernandez V, Osorio A, Benítez J, Martinez-Delgado B | 5. | AV628 | 2015 | E | INTERNATIONAL JOURNAL OF CANCER Vol. 136 (3): # 593 - 602 (10), (DOI: 10.1002/ijc.29021) FEB 15 2015WOS | 35 | 33 | 9 | 0 | 23.5714 | MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors | Tanic M, Yanowski K, Gómez-López G, Rodriguez-Pinilla M, Marquez-Rodas I, Osorio A, Pisano D, Martinez-Delgado B, Benítez J | 6. | AV628 | 2015 | E | GENOMICS DATA Vol. 3 (): # 75 - 79 (5), (DOI: 10.1016/j.gdata.2014.11.008) MAR 2015WOS | 11 | 11 | 8 | 0 | 9.1667 | miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors | Tanic M, Yanowski K, Andrés E, Gómez-López G, Socorro M, Pisano D, Martinez-Delgado B, Benítez J | 7. | AV628 | 2016 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 163 (): # 362 - 373 (12), (DOI: 10.1016/j.jinorgbio.2016.04.011) OCT 2016WOS | 20 | 20 | 6 | 0 | 20.0000 | Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium(II)-arene complex with an isoquinoline-3-carboxylic acid ligand | Jovanovic K, Tanic M, Ivanovic I, Gligorijevic N, Dojcinovic B, Radulovic S | 8. | AV628 | 2016 | E | JOURNAL OF BUON Vol. 21 (5): # 1287 - 1295 (9), (DOI: ) SEP-OCT 2016WOS | 17 | 16 | 11 | 0 | 8.8889 | Pharmacogenetics in cancer therapy-8 years of experience at the Institute for Oncology and Radiology of Serbia | Cavic M, Krivokuca A, Boljevic I, Brotto K, Jovanovic K, Tanic M, Filipovic L, Zec M, Malisic E, Jankovic R, Radulovic S | 9. | AV628 | 2017 | E | CURRENT OPINION IN GENETICS & DEVELOPMENT Vol. 42 (): # 48 - 55 (8), (DOI: 10.1016/j.gde.2017.01.017) FEB 2017WOS | 25 | 23 | 2 | 0 | 23.0000 | Epigenome-wide association studies for cancer biomarker discovery in circulating cell-free DNA: technical advances and challenges | Tanic M, Beck S | 10. | AV628 | 2017 | E | NATURE MATERIALS Vol. 16 (11): # 1056 - 1057 (2), (DOI: 10.1038/nmat5019) NOV 2017WOS | 3 | 3 | 2 | 0 | 3.0000 | Treasure trove for cancer medicine | Tanic M, Beck S | 11. | AV628 | 2017 | E | BMC BIOINFORMATICS Vol. 18 (): #354 1 - 10 (10), (DOI: 10.1186/s12859-017-1753-2) JUL 25 2017WOS | 17 | 17 | 7 | 0 | 17.0000 | Quantification of tumour evolution and heterogeneity via Bayesian epiallele detection | Barrett J, Feber A, Herrero J, Tanic M, Wilson G, Swanton C, Beck S | 12. | AV628 | 2017 | E | JOURNAL OF BUON Vol. 22 (2): # 325 - 333 (9), (DOI: ) MAR-APR 2017WOS | 12 | 11 | 8 | 0 | 9.1667 | Tumor response and patient outcome after preoperative radiotherapy in locally advanced non-inflammatory breast cancer patients | Mladenovic J, Susnjar S, Tanic M, Jankovic R, Karadzic K, Gavrilovic D, Stojanovic S, Plesinac-Karapandzic V | 13. | AV628 | 2018 | E | RADIATION ONCOLOGY Vol. 13 (): #193 - (10), (DOI: 10.1186/s13014-018-1129-4) OCT 1 2018WOS | 17 | 16 | 9 | 0 | 11.4286 | Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer | Tanic M, Krivokuca A, Cavic M, Mladenovic J, Karapandzic V, Beck S, Radulovic S, Susnjar S, Jankovic R | 14. | AV628 | 2019 | E | NATURE Vol. 567 (7749): # 479 - + (22), (DOI: 10.1038/s41586-019-1032-7) MAR 28 2019WOS | 697 | 603 | 249 | 0 | 12.2065 | Neoantigen-directed immune escape in lung cancer evolution | Rosenthal R, Cadieux E, Salgado R, Al B, Moore D, Hiley C, Lund T, Tanic M, Reading J, Joshi K, Henry J, Ghorani E, Wilson G, Birkbak N, Jamal-Hanjani M, Veeriah S, Szallasi Z, Loi S, Hellmann M, Feber A, Chain B, Herrero J, Quezada S, Demeulemeester J, Van L, Beck S, McGranahan N, Swanton C, Swanton C, Jamal-Hanjani M, ... | 15. | AV628 | 2020 | M23 | E | Article | JOURNAL OF BUON Vol. 25 (6): # 2635 - 2642 (8), (DOI: ) NOV-DEC 2020WOS | 8 | 7 | 10 | 1.8750 | 4.3750 | EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia | Cavic M, Krivokuca A, Pavlovic M, Boljevic I, Rakobradovic J, Mihajlovic M, Tanic M, Damjanovic A, Malisic E, Jankovic R | 16. | AV628 | 2021 | M21a+ | E | Article | NATURE Vol. 597 (7877): # 555 - + (25), (DOI: 10.1038/s41586-021-03894-5) SEP 23 2021WOS | 49 | 39 | 13 | 12.5000 | 24.3750 | Using DNA sequencing data to quantify T cell fraction and therapy response | Bentham R, Litchfield K, Watkins T, Lim E, Rosenthal R, Martínez-Ruiz C, Hiley C, Al B, Salgado R, Moore D, Jamal-Hanjani M, Swanton C, McGranahan N | 17. | AV628 | 2022 | M21a+ | E | Article | NATURE BIOTECHNOLOGY Vol. 40 (10): # 1478 - + (21), (DOI: 10.1038/s41587-022-01336-9) OCT 2022WOS | 10 | 6 | 9 | 20.0000 | 6.0000 | Comparison and imputation-aided integration of five commercial platforms for targeted DNA methylome analysis | Tanic M, Moghul I, Rodney S, Dhami P, Vaikkinen H, Ambrose J, Barrett J, Feber A, Beck S | 18. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7957): # 543 - + (31), (DOI: 10.1038/s41586-023-05706-4) APR 20 2023WOS | 139 | 73 | 46 | 2.4390 | 8.9024 | Genomic-transcriptomic evolution in lung cancer and metastasis | Martínez-Ruiz C, Black J, Puttick C, Hill M, Demeulemeester J, Cadieux E, Thol K, Jones T, Veeriah S, Naceur-Lombardelli C, Toncheva A, Prymas P, Rowan A, Ward S, Cubitt L, Athanasopoulou F, Pich O, Karasaki T, Moore D, Salgado R, Colliver E, Castignani C, Dietzen M, Huebner A, Al B, Tanic M, Watkins T, Lim E, Al-Rashed A, Lang D, ... | 19. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7957): # 534 - + (34), (DOI: 10.1038/s41586-023-05729-x) APR 20 2023WOS | 149 | 73 | 286 | 0.3559 | 1.2989 | The evolution of non-small cell lung cancer metastases in TRACERx | Al B, Huebner A, Martínez-Ruiz C, Grigoriadis K, Watkins T, Pich O, Moore D, Veeriah S, Ward S, Laycock J, Johnson D, Rowan A, Razaq M, Akther M, Naceur-Lombardelli C, Prymas P, Toncheva A, Hessey S, Dietzen M, Colliver E, Frankell A, Bunkum A, Lim E, Karasaki T, Abbosh C, Hiley C, Hill M, Cook D, Wilson G, Salgado R, ... | 20. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7957): # 563 - + (34), (DOI: 10.1038/s41586-023-05771-9) APR 20 2023WOS | 191 | 92 | 51 | 2.1739 | 10.0000 | Antibodies against endogenous retroviruses promote lung cancer immunotherapy | Ng K, Boumelha J, Enfield K, Almagro J, Cha H, Pich O, Karasaki T, Moore D, Salgado R, Sivakumar M, Young G, Molina-Arcas M, Trecesson S, Anastasiou P, Fendler A, Au L, Shepherd S, Martinez-Ruiz C, Puttick C, Black J, Watkins T, Kim H, Shim S, Faulkner N, Attig J, Veeriah S, Magno N, Ward S, Frankell A, Al B, ... | 21. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7957): # 553 - + (44), (DOI: 10.1038/s41586-023-05776-4) APR 20 2023WOS | 233 | 112 | 54 | 2.0408 | 11.4286 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA | Abbosh C, Frankell A, Harrison T, Kisistok J, Garnett A, Johnson L, Veeriah S, Moreau M, Chesh A, Chaunzwa T, Weiss J, Schroeder M, Ward S, Grigoriadis K, Shahpurwalla A, Litchfield K, Puttick C, Biswas D, Karasaki T, Black J, Martínez-Ruiz C, Al B, Pich O, Watkins T, Lim E, Huebner A, Moore D, Godin-Heymann N, L'Hernault A, Bye H, ... | 22. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7957): # 525 - + (40), (DOI: 10.1038/s41586-023-05783-5) APR 20 2023WOS | 191 | 99 | 285 | 0.3571 | 1.7679 | The evolution of lung cancer and impact of subclonal selection in TRACERx | Frankell A, Dietzen M, Al B, Lim E, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A, Hill M, Grigoriadis K, Moore D, Black J, Liu W, Thol K, Pich O, Watkins T, Naceur-Lombardelli C, Cook D, Salgado R, Wilson G, Bailey C, Angelova M, Bentham R, Martínez-Ruiz C, Abbosh C, Nicholson A, Le Q, Biswas D, ... | 23. | AV628 | 2023 | M21a+ | E | Article | NATURE Vol. 616 (7955): # 159 - + (37), (DOI: 10.1038/s41586-023-05874-3) APR 6 2023WOS | 514 | 270 | 72 | 1.4925 | 20.1493 | Lung adenocarcinoma promotion by air pollutants | Hill W, Lim E, Weeden C, Lee C, Augustine M, Chen K, Kuan F, Marongiu F, Evans E, Moore D, Rodrigues F, Pich O, Bakker B, Cha H, Myers R, van M, Boumelha J, Veeriah S, Rowan A, Naceur-Lombardelli C, Karasaki T, Sivakumar M, De S, Caswell D, Nagano A, Black J, Martínez-Ruiz C, Ryu M, Huff R, Li S, ... | 24. | AV628 | 2023 | M21a+ | E | Article | NATURE MEDICINE Vol. (): # - (40), (DOI: 10.1038/s41591-023-02230-w) 2023 APR 12 2023WOS | 69 | 27 | 289 | 0.3521 | 0.4754 | Evolutionary characterization of lung adenocarcinoma morphology in TRACERx | Karasaki T, Moore D, Veeriah S, Naceur-Lombardelli C, Toncheva A, Magno N, Ward S, Al B, Watkins T, Grigoriadis K, Huebner A, Hill M, Frankell A, Abbosh C, Puttick C, Zhai H, Gimeno-Valiente F, Saghafinia S, Kanu N, Dietzen M, Pich O, Lim E, Martínez-Ruiz C, Black J, Biswas D, Campbell B, Lee C, Colliver E, Enfield K, Hessey S, ... | 25. | AV628 | 2023 | M21a+ | E | Article | NATURE MEDICINE Vol. (): # - (32), (DOI: 10.1038/s41591-023-02232-8) 2023 APR 12 2023WOS | 79 | 33 | 302 | 0.3367 | 0.5556 | Body composition and lung cancer-associated cachexia in TRACERx | Al-Sawaf O, Weiss J, Skrzypski M, Lam J, Karasaki T, Zambrana F, Kidd A, Frankell A, Watkins T, Martínez-Ruiz C, Puttick C, Black J, Huebner A, Al B, Sokac M, Collins S, Veeriah S, Magno N, Naceur-Lombardelli C, Prymas P, Toncheva A, Ward S, Jayanth N, Salgado R, Bridge C, Christiani D, Mak R, Bay C, Rosenthal M, Sattar N, ... | 26. | AV628 | 2023 | M21a | E | Article | JOURNAL OF MOLECULAR MEDICINE-JMM Vol. 101 (8): # 1001 - 1014 (14), (DOI: 10.1007/s00109-023-02339-y) AUG 2023WOS | 2 | 2 | 8 | 10.0000 | 1.6667 | Nischarin expression may have differing roles in male and female melanoma patients | Ostojic M, Jevric M, Mitrovic-Ajtic O, Zivic K, Tanic M, Cavic M, Srdic-Rajic T, Grahovac J | 27. | AV628 | 2023 | M21a | E | Article | JOURNAL OF CLINICAL MEDICINE Vol. 12 (11): #3641 - (16), (DOI: 10.3390/jcm12113641) MAY 24 2023WOS | 7 | 3 | 13 | 5.4545 | 1.3636 | Prediction of Cervical Lymph Node Metastasis in Clinically Node-Negative T1 and T2 Papillary Thyroid Carcinoma Using Supervised Machine Learning Approach | Krneta M, Saranovic D, Teodorovic L, Krajcinovic N, Avramovic N, Bojovic Z, Bukumiric Z, Markovic I, Rajsic S, Djorovic B, Artiko V, Karlicic M, Tanic M | 28. | AV628 | 2023 | M21 | E | Article | TRANSLATIONAL ONCOLOGY Vol. 37 (): #101772 - (8), (DOI: 10.1016/j.tranon.2023.101772) NOV 2023WOS | 4 | 3 | 9 | 5.7143 | 2.1429 | EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia | Vukovic M, Tanic M, Damjanovic A, Pavlovic M, Stanojevic A, Zivic K, Karadzic V, Jankovic R, Cavic M | 29. | AV628 | 2024 | M21a+ | E | Article | NATURE COMMUNICATIONS Vol. 15 (1): #4653 - (21), (DOI: 10.1038/s41467-024-47547-3) MAY 31 2024WOS | 16 | 4 | 36 | 3.2258 | 0.6452 | Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models | Hynds R, Huebner A, Pearce D, Hil M, Akarca A, Moore D, Ward S, Gowers K, Karasaki T, Al B, Wilson G, Pich O, Martínez-Ruiz C, Hossain A, Pearce S, Sivakumar M, Ben A, Grönroos E, Chandrasekharan D, Kolluri K, Towns R, Wang K, Cook D, Bosshard-Carter L, Naceur-Lombardelli C, Rowan A, Veeriah S, Litchfield K, Crosbie P, Dive C, ... | 30. | AV628 | 2024 | M21a+ | E | Article | NATURE COMMUNICATIONS Vol. 15 (1): #4871 - (21), (DOI: 10.1038/s41467-024-47606-9) JUN 13 2024WOS | 30 | 4 | 47 | 2.3810 | 0.4762 | Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling | Hobor S, Al B, Hiley C, Skrzypski M, Frankell A, Bakker B, Watkins T, Markovets A, Dry J, Brown A, van d, van d, Spierings D, Oukrif D, Novelli M, Chakrabarti T, Rabinowitz A, Hassou L, Litière S, Kerr D, Tan L, Kelly G, Moore D, Renshaw M, Venkatesan S, Hill W, Huebner A, Martínez-Ruiz C, Black J, Wu W, ... | 31. | AV628 | 2024 | M21a+ | E | Article | NATURE GENETICS Vol. 56 (10): # 2121 - + (28), (DOI: 10.1038/s41588-024-01883-8) OCT 2024WOS | 23 | 1 | 22 | 5.8824 | 0.2941 | MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution | Puttick C, Jones T, Leung M, Galvez-Cancino F, Liu J, Varas-Godoy M, Rowan A, Pich O, Martinez-Ruiz C, Bentham R, Dijkstra K, Black J, Rosenthal R, Kanu N, Litchfield K, Salgado R, Moore D, Van L, Jamal-Hanjani M, Quezada S, Swanton C, McGranahan N | 32. | AV628 | 2024 | M21a+ | E | Article | NATURE CANCER Vol. (): # - (29), (DOI: 10.1038/s43018-023-00694-w) 2024 JAN 10 2024WOS | 26 | 3 | 291 | 0.3497 | 0.0524 | The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma | Pan X, Abduljabbar K, Coelho-Lima J, Grapa A, Zhang H, Cheung A, Baena J, Karasaki T, Wilson C, Sereno M, Veeriah S, Aitken S, Hackshaw A, Nicholson A, Jamal-Hanjani M, Swanton C, Jamal-Hanjani M, Zhang H, AbdulJabbar K, Pan X, Yuan Y, Hackshaw A, Le Q, Veeriah S, Karasaki T, Janes S, Hacker A, Sharp A, Smith S, Dhanda H, ... | 33. | AV628 | 2024 | M21a | E | Article | BIOMEDICINES Vol. 12 (10): #2278 - (19), (DOI: 10.3390/biomedicines12102278) OCT 2024WOS | 1 | 0 | 19 | 3.5294 | 0.0000 | Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia-Insights from the Institute for Oncology and Radiology of Serbia | Cavic M, Nikolic N, Marinkovic M, Damjanovic A, Krivokuca A, Tanic M, Radulovic M, Stanojevic A, Pejnovic L, Crnogorac M, Djuric A, Vukovic M, Stevanovic V, Kijac J, Karadzic V, Nikolic S, Stojanovic-Rundic S, Jankovic R, Spasic J | 34. | AV628 | 2024 | M21 | E | Review | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Vol. 25 (23): #12669 - (19), (DOI: 10.3390/ijms252312669) DEC 2024WOS | 4 | 0 | 4 | 8.0000 | 0.0000 | Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy | Grahovac J, Duric A, Tanic M, Krivokuca A | 35. | AV628 | 2024 | M21a+ | E | Correction | NATURE Vol. 631 (8022): # E16 - E16 (1), (DOI: 10.1038/s41586-024-07738-w) JUL 25 2024WOS | 2 | 0 | 80 | 0 | 0.0000 | The evolution of lung cancer and impact of subclonal selection in TRACERx (vol 616, pg 525, 2023) | Frankell A, Dietzen M, Al B, Lim E, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A, Hill M, Grigoriadis K, Moore D, Black J, Liu W, Thol K, Pich O, Watkins T, Naceur-Lombardelli C, Cook D, Salgado R, Wilson G, Bailey C, Angelova M, Bentham R, Martínez-Ruiz C, Abbosh C, Nicholson A, Le Q, Biswas D, ... | 36. | AV628 | 2024 | M21 | E | Editorial Material | FRONTIERS IN GENETICS Vol. 15 (): #1421500 - (2), (DOI: 10.3389/fgene.2024.1421500) MAY 8 2024WOS | 1 | 0 | 3 | 0 | 0.0000 | Editorial: Epigenetic biomarkers for cancer risk stratification and patient management | Tanic M, Ecker S, Lyskjaer I | 37. | AV628 | 2025 | E | SEMINARS IN CANCER BIOLOGY Vol. 109 (): # 101 - 124 (24), (DOI: 10.1016/j.semcancer.2025.01.003) FEB 2025WOS | 1 | 0 | 20 | 0 | 0.0000 | Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications | Tost J, Ak-Aksoy S, Campa D, Corradi C, Farinella R, Ibáñez-Costa A, Dubrot J, Earl J, Melian E, Kataki A, Kolnikova G, Madjarov G, Chaushevska M, Strnadel J, Tanic M, Tomas M, Dubovan P, Urbanova M, Buocikova V, Smolkova B |
|---|
27. 04. 2026.; 00:05:07; Trajanje procesiranja: 0.022 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).